Gamma-interferon (IFN- γ) plays an important role in the maintenance of immune homeostasis by regulating the functions of all key cells of the immune system. Pathologically, IFN- γ has been implicated in several autoimmune diseases. Since estrogens affect autoimmunity, we investigated whether immunomodulatory estrogenic hormones affects IFN- γ. Concanavalin-A-stimulated splenic lymphocytes from orchiectomized or ovariectomized C57BL/6 mice exposed to estrogen for 3–5 months secreted higher levels of IFN- γ protein compared to controls. This increase is, in part, due to increased levels of IFN- γ mRNA. Kinetic studies suggested that splenic lymphocytes from estrogen-treated gonadectomized mice had increased IFN- γ mRNA and protein as early as 6–12 h of culture. Estrogen also increased the expression of co-stimulatory CD80 (B7-1) molecules on B cells. Since natural estrogen increases IFN- γ, it became important to test whether diethylstilbestrol (DES, a synthetic estrogen which was given to millions of women) also alters IFN- γ levels. Our initial investigatory studies show that prenatal mice exposed to DES had a normal ability to secrete IFN- γ. However, a second exposure of these mice to DES (single dose of 1 μg/g.b.w), as late as 1–1.5 years of age, led to a pronounced increase in the number of IFN- γ secreting cells and augmented secretion of IFN- γ. Increased IFN- γ secretion by splenic lymphocytes from these mice was noted even after stimulation with a submitogenic concentration of anti-CD3 antibodies with or without anti-CD28 antibodies. Cell mixing experiments suggested that the DES-induced increase in IFN- γ secretion is due to hormonal effects on T cells but not on APC. Together our studies show that: (1) estrogens upregulate IFN- γ secretion, a vital immunoregulatory cytokine, and (2) inappropriate exposure of developing fetus to DES may permanently alter the ‘cytokine programming’ of lymphocytes.
Read full abstract